Sphera Funds Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Sphera Funds Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-81,000	Closed	-$11M	–	139
2020 Q3	$11M	Sell	81,000 -19,000	-19%	-$2.02M	1.09%	23
2020 Q2	$9.66M	Buy	+100,000	New	+$8.34M	0.91%	26
2019 Q3	–	Sell	-140,000	Closed	-$7.02M	–	110
2019 Q2	$7.02M	Buy	140,000 +27,000	+24%	+$1.31M	0.96%	31
2019 Q1	$5.88M	Buy	+113,000	New	+$5.21M	0.54%	43
2017 Q1	–	Sell	-83,240	Closed	-$1.08M	–	131
2016 Q4	$1.08M	Hold	83,240	–	–	0.27%	82
2016 Q3	$1.36M	Buy	+83,240	New	+$1.5M	0.22%	88

Sphera Funds Management's MYOK Position: Q4 2020 in Review

Sphera Funds Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 81,000 shares — an estimated $11M sold.

Sphera Funds Management first reported a position in MYOK in Q3 2016 and held it in 6 quarters. The position peaked at $11M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Sphera Funds Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Sphera Funds Management sold 81,000 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $11M.
Sphera Funds Management first reported a position in MyoKardia, Inc. Common Stock in Q3 2016 and held it in 6 quarters.
Sphera Funds Management's MyoKardia, Inc. Common Stock position peaked at $11M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Sphera Funds Management's 13F filing for Q4 2020, filed 16 Feb 2021.